November 17, 2023, Neogenomics Inc. (NASDAQ: NEO) trading session started at the price of $18.16, that was 8.01% jump from the session before. During the day, the shares moved up to $19.44 and dropped to $18.12 before settling in for the closing price of $17.97. A 52-week range for NEO has been $8.70 – $20.54.
Annual sales at Healthcare sector company grew by 17.17% over the past five years. When this article was written, the company’s average yearly earnings per share was at 67.86%. With a float of $125.79 million, this company’s outstanding shares have now reached $126.91 million.
Let’s look at the performance matrix of the company that is accounted for 2100 employees. In terms of profitability, gross margin is +33.99, operating margin of -29.55, and the pretax margin is -31.26.
Neogenomics Inc. (NEO) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Neogenomics Inc. stocks. The insider ownership of Neogenomics Inc. is 1.31%, while institutional ownership is 95.55%.
Neogenomics Inc. (NEO) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/29/2023, it has been observed that the corporation posted $0 earnings per share (EPS) during the time that was better than consensus figure (set at -$0.07) by $0.07. This company achieved a net margin of -28.30 while generating a return on equity of -13.70. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 67.86% per share during the next fiscal year.
Neogenomics Inc. (NASDAQ: NEO) Trading Performance Indicators
You can see what Neogenomics Inc. (NEO) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.06. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.30.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.77, a number that is poised to hit -0.03 in the next quarter and is forecasted to reach -0.08 in one year’s time.
Technical Analysis of Neogenomics Inc. (NEO)
Neogenomics Inc. (NASDAQ: NEO) saw its 5-day average volume 0.99 million, a positive change from its year-to-date volume of 0.98 million. As of the previous 9 days, the stock’s Stochastic %D was 96.99%. Additionally, its Average True Range was 0.89.
During the past 100 days, Neogenomics Inc.’s (NEO) raw stochastic average was set at 99.64%, which indicates a significant increase from 99.51% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 76.31% in the past 14 days, which was higher than the 54.56% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.84, while its 200-day Moving Average is $15.50. Nevertheless, the first resistance level for the watch stands at $19.86 in the near term. At $20.31, the stock is likely to face the second major resistance level. The third major resistance level sits at $21.18. If the price goes on to break the first support level at $18.54, it is likely to go to the next support level at $17.67. The third support level lies at $17.22 if the price breaches the second support level.
Neogenomics Inc. (NASDAQ: NEO) Key Stats
There are 127,466K outstanding shares of the company, which has a market capitalization of 2.47 billion. As of now, sales total 509,730 K while income totals -144,250 K. Its latest quarter income was 151,950 K while its last quarter net income were -18,520 K.